Billionaire Profile
D
Global Rank
#2814

Image: Unknown Author | CC BY-SA 4.0 | via Wikimedia Commons

Dilip Surana

CEO, Pharmaceuticals
INDIA
Real-Time Net Worth
$1.275B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
0% (24h)
Age
60
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

Dilip Surana is an Indian billionaire and the Chairman and Managing Director of Micro Labs, a major pharmaceutical company. His net worth of $1.5 billion is primarily derived from his leadership of Micro Labs, a company founded by his father. Surana has expanded Micro Labs' reach and product portfolio, making it a significant player in the global generics market. His career is marked by achievements in expanding operations and diversifying the company's product range, with a focus on making quality healthcare accessible. Dilip Surana is known for his commitment to philanthropy, especially in healthcare and education, and for his people-oriented leadership style.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Dilip Surana was born in India, though his exact date of birth is not publicly available. He completed his schooling from Bishop Cotton Boys high school in Bangalore. He earned a Bachelor's Degree in Pharmacy from the University of Bangalore. He also earned a Bachelor of Commerce (Accounts) degree from St. Joseph's College of Commerce in 1985 with flying colors. His family has a background in the pharmaceutical sector; his father, G.C. Surana, founded Micro Labs in 1973.

Rise to Success

After completing his education, Dilip Surana joined Micro Labs in 1983. He took over operations of the family business, absorbing the nuances of corporate management. Under his leadership, the company expanded significantly and became a key player in the global generics market. Surana played a pivotal role in diversifying Micro Labs' product portfolio and establishing a strong presence in emerging markets. His strategies included expanding production capabilities and focusing on generics and specialty pharmaceuticals.

Key Business Strategies

Dilip Surana focused on expanding Micro Labs beyond its initial scope. His key business strategies included diversifying the company's product portfolio, focusing on generics and specialty pharmaceuticals, and expanding production capabilities. He introduced specialty divisions, including Cardiology, Neuropsychiatry, and Ophthalmology. He also set stringent quality standards for Micro Labs, and established world-class research and manufacturing facilities. During the COVID-19 pandemic, Micro Labs' product, Dolo-650, saw a surge in sales.

Philanthropy

Dilip Surana is actively involved in philanthropy, with a strong focus on improving education and healthcare access. He has supported organizations like the Akshaya Patra Foundation, demonstrating his commitment to social impact across India. The GDA Foundation, founded by his father, supports hospitals, schools, and research centers, providing free medical help and scholarships.

Career Milestones

1983

Joined Micro Labs

Began working at the family business, Micro Labs.

1994

Launched specialty divisions

Pioneered the concept of specialty divisions in the Indian Pharmaceutical Industry, including Cardiology, Neuropsychiatry, and Ophthalmology.

2010

Outstanding Entrepreneur of the year

Recognized as the 'Outstanding Entrepreneur of the year' in the pharmaceutical industry.

Philanthropy & Social Impact

Healthcare and Education

GDA Foundation

Undisclosed

Supports hospitals, schools, and research centers; provides free medical help and scholarships.

Business Philosophy & Leadership

Notable Quotes

""The biggest risk is not taking any risk in a world that is changing really quick the only strategy that is guaranteed to fail is not taking risks.""

Leadership Principles

People-oriented leadership

Focuses on creating overall success and building lasting relationships with employees.

Discipline

Emphasizes discipline in both professional and personal life.

Controversies & Challenges

2022

Tax Evasion Allegations

India's tax authority alleged that Micro Labs gave freebies worth 10 billion rupees to doctors to push drug sales; the company denied any wrongdoing.